Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastases, Brain
Interventions: DRUG: capecitabine|DRUG: lapatinib|DRUG: trastuzumab
Sponsor: Novartis Pharmaceuticals